Jci_page_head_homepage_01 Jci_page_head_homepage_02
Rachel M. McLoughlin, Janusz Witowski, Rachel L. Robson, Thomas S. Wilkinson, Suzanne M. Hurst, Anwen S. Williams, John D. Williams, Stefan Rose-John, Simon A. Jones, Nicholas Topley
Published in Volume 112, Issue 4
J Clin Invest. 2003; 112(4):598–607 doi:10.1172/JCI17129
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

IL-1β and IL-6 production after SES-induced peritoneal inflammation in wild-type and IFN-γ–/– mice. (a) Wild-type or IFN-γ–/– mice were intraperitoneally administered with PBS or SES. At specific time intervals, mice were sacrificed, and intraperitoneal IL-1β levels were quantified using ELISA (*P < 0.05 versus PBS). (b) Wild-type or IFN-γ–/– mice were intraperitoneally administered with PBS, SES, IFN-γ (0.5 U per mouse), or a combination of SES and IFN-γ. Intraperitoneal IL-6 levels were quantified at defined time intervals (*P < 0.05 versus IFN-γ–/– plus SES alone). The lower panels show wild-type and IFN-γ–/– mice treated with PBS alone. Values represent the mean ± SEM (n = 6 mice per condition).